Relevance and feasibility of a systematic screening of multimorbidities in patients with chronic inflammatory rheumatic diseases
•Systematic screening of multimorbidities is efficient.•Systematic screening of multimorbidities is feasible in one-day clinic.•Screening for lung diseases should be added to this systematic screening. EULAR recently proposed to screen multimorbidities in chronic inflammatory rheumatic diseases. The...
Gespeichert in:
| Veröffentlicht in: | Joint, bone, spine : revue du rhumatisme bone, spine : revue du rhumatisme, 2019-01, Vol.86 (1), p.49-54 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 54 |
|---|---|
| container_issue | 1 |
| container_start_page | 49 |
| container_title | Joint, bone, spine : revue du rhumatisme |
| container_volume | 86 |
| creator | Daïen, Claire I. Tubery, Amandine Beurai-Weber, Mégane du Cailar, Guilhem Picot, Marie-Christine Jaussent, Audrey Roubille, François Cohen, Jean-David Morel, Jacques Bousquet, Jean Fesler, Pierre Combe, Bernard |
| description | •Systematic screening of multimorbidities is efficient.•Systematic screening of multimorbidities is feasible in one-day clinic.•Screening for lung diseases should be added to this systematic screening.
EULAR recently proposed to screen multimorbidities in chronic inflammatory rheumatic diseases. The aims of the study were to define the most common multimorbidities in chronic inflammatory rheumatic diseases, compare the screening approach performed in the clinic with the recent EULAR recommendations, validate the points to consider for the systematic standardized multimorbidity screening proposed by EULAR and assess feasibility of such a screening in a daily clinic.
Data were collected prospectively during a 1-day multimorbidity clinic. Diabetes, hypertension, CVD damage, chronic respiratory diseases, osteoporosis and preventive measures were assessed. The comparison with EULAR points to consider was performed retrospectively.
We included 200 consecutive patients (157 with rheumatoid arthritis, 37 spondyloarthritis, and 6 connective tissue diseases or vasculitis). The most common multimorbidities already diagnosed in our patients were hypertension (26%) and diabetes (7.5%). Screening showed that 61.5% (CI95%: 54.6%-67.9%) patients presented at least one undiagnosed or uncontrolled diseases: diabetes (6%), hypertension (20.6%), dyslipidemia (16.1%) valvulopathies (16.8%), peripheral artery disease (4.5%); carotid stenosis (6.5%) and aortic aneurysm (5.5%). Overall, 39.9% patients had incomplete cancer screening and 52.8% incomplete vaccine schedule. Undiagnosed pulmonary obstruction and risk of sleep apnea were suspected in 15.5% and 40.1% patients, respectively.
This study underlines the relevance of a systematic screening of multimorbidities in chronic inflammatory rheumatic diseases and its feasibility in a 1-day clinic. Spirometry and sleep apnea screening should be added to EULAR points to consider. The long-term impact of such screening needs to be evaluated. |
| doi_str_mv | 10.1016/j.jbspin.2018.03.016 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_hal_p</sourceid><recordid>TN_cdi_hal_primary_oai_HAL_hal_01790556v2</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1297319X18300599</els_id><sourcerecordid>2025318810</sourcerecordid><originalsourceid>FETCH-LOGICAL-c442t-d99d96867ea6b001282cea2d7470bdad3063ca3d83c60f24359cbfb0f83b08013</originalsourceid><addsrcrecordid>eNp9kVGL1DAUhYso7rr6D0TyqA8db5I2bV-EZVndhQFBFHwLaXLr3KFNxyQdmTd_uhm6u48-Jdz7nXPgnqJ4y2HDgauP-82-jwfyGwG83YDc5OGz4pI3TVs2oq6e57_omlLy7udF8SrGPQBIUauXxYXoVF11VXdZ_P2GIx6Nt8iMd2xAE6mnkdKJzQMzLJ5iwskksizagOjJ_zpvpmVMNM2hJ0eJMDLy7JAx9CmyP5R2zO7C7LOM_DCaKVvM4cTCDpfVzVHMWRhfFy8GM0Z88_BeFT8-336_uSu3X7_c31xvS1tVIpWu61ynWtWgUT0AF62waIRrqgZ6Z5wEJa2RrpVWwSAqWXe2H3oYWtlDC1xeFR9W350Z9SHQZMJJz4b03fVWn2fAmw7qWh1FZt-v7CHMvxeMSU8ULY6j8TgvUQsQteRtyyGj1YraMMcYcHjy5qDPPem9XnvS5540yByksuzdQ8LST-ieRI_FZODTCmC-yZEw6GjzcS06CmiTdjP9P-EfXmqoZw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2025318810</pqid></control><display><type>article</type><title>Relevance and feasibility of a systematic screening of multimorbidities in patients with chronic inflammatory rheumatic diseases</title><source>MEDLINE</source><source>ScienceDirect Journals (5 years ago - present)</source><creator>Daïen, Claire I. ; Tubery, Amandine ; Beurai-Weber, Mégane ; du Cailar, Guilhem ; Picot, Marie-Christine ; Jaussent, Audrey ; Roubille, François ; Cohen, Jean-David ; Morel, Jacques ; Bousquet, Jean ; Fesler, Pierre ; Combe, Bernard</creator><creatorcontrib>Daïen, Claire I. ; Tubery, Amandine ; Beurai-Weber, Mégane ; du Cailar, Guilhem ; Picot, Marie-Christine ; Jaussent, Audrey ; Roubille, François ; Cohen, Jean-David ; Morel, Jacques ; Bousquet, Jean ; Fesler, Pierre ; Combe, Bernard</creatorcontrib><description>•Systematic screening of multimorbidities is efficient.•Systematic screening of multimorbidities is feasible in one-day clinic.•Screening for lung diseases should be added to this systematic screening.
EULAR recently proposed to screen multimorbidities in chronic inflammatory rheumatic diseases. The aims of the study were to define the most common multimorbidities in chronic inflammatory rheumatic diseases, compare the screening approach performed in the clinic with the recent EULAR recommendations, validate the points to consider for the systematic standardized multimorbidity screening proposed by EULAR and assess feasibility of such a screening in a daily clinic.
Data were collected prospectively during a 1-day multimorbidity clinic. Diabetes, hypertension, CVD damage, chronic respiratory diseases, osteoporosis and preventive measures were assessed. The comparison with EULAR points to consider was performed retrospectively.
We included 200 consecutive patients (157 with rheumatoid arthritis, 37 spondyloarthritis, and 6 connective tissue diseases or vasculitis). The most common multimorbidities already diagnosed in our patients were hypertension (26%) and diabetes (7.5%). Screening showed that 61.5% (CI95%: 54.6%-67.9%) patients presented at least one undiagnosed or uncontrolled diseases: diabetes (6%), hypertension (20.6%), dyslipidemia (16.1%) valvulopathies (16.8%), peripheral artery disease (4.5%); carotid stenosis (6.5%) and aortic aneurysm (5.5%). Overall, 39.9% patients had incomplete cancer screening and 52.8% incomplete vaccine schedule. Undiagnosed pulmonary obstruction and risk of sleep apnea were suspected in 15.5% and 40.1% patients, respectively.
This study underlines the relevance of a systematic screening of multimorbidities in chronic inflammatory rheumatic diseases and its feasibility in a 1-day clinic. Spirometry and sleep apnea screening should be added to EULAR points to consider. The long-term impact of such screening needs to be evaluated.</description><identifier>ISSN: 1297-319X</identifier><identifier>EISSN: 1778-7254</identifier><identifier>DOI: 10.1016/j.jbspin.2018.03.016</identifier><identifier>PMID: 29654949</identifier><language>eng</language><publisher>France: Elsevier Masson SAS</publisher><subject>Aged ; Arthritis, Rheumatoid - epidemiology ; Cardiovascular disease risk ; Chronic Disease - epidemiology ; Connective Tissue Diseases - epidemiology ; EULAR point to consider ; Feasibility Studies ; Female ; Human health and pathology ; Humans ; Life Sciences ; Lung disease ; Lung Diseases - epidemiology ; Lupus Erythematosus, Systemic - epidemiology ; Male ; Mass Screening - methods ; Middle Aged ; Multimorbidity ; Polymyositis ; Psoriatic arthritis ; Rheumatic Diseases - epidemiology ; Rheumatoid arthritis ; Rhumatology and musculoskeletal system ; Risk Assessment ; Risk Factors ; Santé publique et épidémiologie ; Screening ; Spondylarthritis - epidemiology ; Spondyloarthritis ; Vaccination ; Vasculitis - epidemiology</subject><ispartof>Joint, bone, spine : revue du rhumatisme, 2019-01, Vol.86 (1), p.49-54</ispartof><rights>2018 Société française de rhumatologie</rights><rights>Copyright © 2018 Société française de rhumatologie. Published by Elsevier Masson SAS. All rights reserved.</rights><rights>Distributed under a Creative Commons Attribution 4.0 International License</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c442t-d99d96867ea6b001282cea2d7470bdad3063ca3d83c60f24359cbfb0f83b08013</citedby><cites>FETCH-LOGICAL-c442t-d99d96867ea6b001282cea2d7470bdad3063ca3d83c60f24359cbfb0f83b08013</cites><orcidid>0000-0002-4061-4766 ; 0000-0003-4204-7299 ; 0000-0001-7545-6385 ; 0000-0003-4002-1861 ; 0000-0002-5288-9687 ; 0000-0003-0636-9653 ; 0000-0002-7831-6545</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.jbspin.2018.03.016$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>230,314,780,784,885,3548,27923,27924,45994</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/29654949$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://hal.umontpellier.fr/hal-01790556$$DView record in HAL$$Hfree_for_read</backlink></links><search><creatorcontrib>Daïen, Claire I.</creatorcontrib><creatorcontrib>Tubery, Amandine</creatorcontrib><creatorcontrib>Beurai-Weber, Mégane</creatorcontrib><creatorcontrib>du Cailar, Guilhem</creatorcontrib><creatorcontrib>Picot, Marie-Christine</creatorcontrib><creatorcontrib>Jaussent, Audrey</creatorcontrib><creatorcontrib>Roubille, François</creatorcontrib><creatorcontrib>Cohen, Jean-David</creatorcontrib><creatorcontrib>Morel, Jacques</creatorcontrib><creatorcontrib>Bousquet, Jean</creatorcontrib><creatorcontrib>Fesler, Pierre</creatorcontrib><creatorcontrib>Combe, Bernard</creatorcontrib><title>Relevance and feasibility of a systematic screening of multimorbidities in patients with chronic inflammatory rheumatic diseases</title><title>Joint, bone, spine : revue du rhumatisme</title><addtitle>Joint Bone Spine</addtitle><description>•Systematic screening of multimorbidities is efficient.•Systematic screening of multimorbidities is feasible in one-day clinic.•Screening for lung diseases should be added to this systematic screening.
EULAR recently proposed to screen multimorbidities in chronic inflammatory rheumatic diseases. The aims of the study were to define the most common multimorbidities in chronic inflammatory rheumatic diseases, compare the screening approach performed in the clinic with the recent EULAR recommendations, validate the points to consider for the systematic standardized multimorbidity screening proposed by EULAR and assess feasibility of such a screening in a daily clinic.
Data were collected prospectively during a 1-day multimorbidity clinic. Diabetes, hypertension, CVD damage, chronic respiratory diseases, osteoporosis and preventive measures were assessed. The comparison with EULAR points to consider was performed retrospectively.
We included 200 consecutive patients (157 with rheumatoid arthritis, 37 spondyloarthritis, and 6 connective tissue diseases or vasculitis). The most common multimorbidities already diagnosed in our patients were hypertension (26%) and diabetes (7.5%). Screening showed that 61.5% (CI95%: 54.6%-67.9%) patients presented at least one undiagnosed or uncontrolled diseases: diabetes (6%), hypertension (20.6%), dyslipidemia (16.1%) valvulopathies (16.8%), peripheral artery disease (4.5%); carotid stenosis (6.5%) and aortic aneurysm (5.5%). Overall, 39.9% patients had incomplete cancer screening and 52.8% incomplete vaccine schedule. Undiagnosed pulmonary obstruction and risk of sleep apnea were suspected in 15.5% and 40.1% patients, respectively.
This study underlines the relevance of a systematic screening of multimorbidities in chronic inflammatory rheumatic diseases and its feasibility in a 1-day clinic. Spirometry and sleep apnea screening should be added to EULAR points to consider. The long-term impact of such screening needs to be evaluated.</description><subject>Aged</subject><subject>Arthritis, Rheumatoid - epidemiology</subject><subject>Cardiovascular disease risk</subject><subject>Chronic Disease - epidemiology</subject><subject>Connective Tissue Diseases - epidemiology</subject><subject>EULAR point to consider</subject><subject>Feasibility Studies</subject><subject>Female</subject><subject>Human health and pathology</subject><subject>Humans</subject><subject>Life Sciences</subject><subject>Lung disease</subject><subject>Lung Diseases - epidemiology</subject><subject>Lupus Erythematosus, Systemic - epidemiology</subject><subject>Male</subject><subject>Mass Screening - methods</subject><subject>Middle Aged</subject><subject>Multimorbidity</subject><subject>Polymyositis</subject><subject>Psoriatic arthritis</subject><subject>Rheumatic Diseases - epidemiology</subject><subject>Rheumatoid arthritis</subject><subject>Rhumatology and musculoskeletal system</subject><subject>Risk Assessment</subject><subject>Risk Factors</subject><subject>Santé publique et épidémiologie</subject><subject>Screening</subject><subject>Spondylarthritis - epidemiology</subject><subject>Spondyloarthritis</subject><subject>Vaccination</subject><subject>Vasculitis - epidemiology</subject><issn>1297-319X</issn><issn>1778-7254</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kVGL1DAUhYso7rr6D0TyqA8db5I2bV-EZVndhQFBFHwLaXLr3KFNxyQdmTd_uhm6u48-Jdz7nXPgnqJ4y2HDgauP-82-jwfyGwG83YDc5OGz4pI3TVs2oq6e57_omlLy7udF8SrGPQBIUauXxYXoVF11VXdZ_P2GIx6Nt8iMd2xAE6mnkdKJzQMzLJ5iwskksizagOjJ_zpvpmVMNM2hJ0eJMDLy7JAx9CmyP5R2zO7C7LOM_DCaKVvM4cTCDpfVzVHMWRhfFy8GM0Z88_BeFT8-336_uSu3X7_c31xvS1tVIpWu61ynWtWgUT0AF62waIRrqgZ6Z5wEJa2RrpVWwSAqWXe2H3oYWtlDC1xeFR9W350Z9SHQZMJJz4b03fVWn2fAmw7qWh1FZt-v7CHMvxeMSU8ULY6j8TgvUQsQteRtyyGj1YraMMcYcHjy5qDPPem9XnvS5540yByksuzdQ8LST-ieRI_FZODTCmC-yZEw6GjzcS06CmiTdjP9P-EfXmqoZw</recordid><startdate>20190101</startdate><enddate>20190101</enddate><creator>Daïen, Claire I.</creator><creator>Tubery, Amandine</creator><creator>Beurai-Weber, Mégane</creator><creator>du Cailar, Guilhem</creator><creator>Picot, Marie-Christine</creator><creator>Jaussent, Audrey</creator><creator>Roubille, François</creator><creator>Cohen, Jean-David</creator><creator>Morel, Jacques</creator><creator>Bousquet, Jean</creator><creator>Fesler, Pierre</creator><creator>Combe, Bernard</creator><general>Elsevier Masson SAS</general><general>Elsevier Masson</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>1XC</scope><scope>VOOES</scope><orcidid>https://orcid.org/0000-0002-4061-4766</orcidid><orcidid>https://orcid.org/0000-0003-4204-7299</orcidid><orcidid>https://orcid.org/0000-0001-7545-6385</orcidid><orcidid>https://orcid.org/0000-0003-4002-1861</orcidid><orcidid>https://orcid.org/0000-0002-5288-9687</orcidid><orcidid>https://orcid.org/0000-0003-0636-9653</orcidid><orcidid>https://orcid.org/0000-0002-7831-6545</orcidid></search><sort><creationdate>20190101</creationdate><title>Relevance and feasibility of a systematic screening of multimorbidities in patients with chronic inflammatory rheumatic diseases</title><author>Daïen, Claire I. ; Tubery, Amandine ; Beurai-Weber, Mégane ; du Cailar, Guilhem ; Picot, Marie-Christine ; Jaussent, Audrey ; Roubille, François ; Cohen, Jean-David ; Morel, Jacques ; Bousquet, Jean ; Fesler, Pierre ; Combe, Bernard</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c442t-d99d96867ea6b001282cea2d7470bdad3063ca3d83c60f24359cbfb0f83b08013</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Aged</topic><topic>Arthritis, Rheumatoid - epidemiology</topic><topic>Cardiovascular disease risk</topic><topic>Chronic Disease - epidemiology</topic><topic>Connective Tissue Diseases - epidemiology</topic><topic>EULAR point to consider</topic><topic>Feasibility Studies</topic><topic>Female</topic><topic>Human health and pathology</topic><topic>Humans</topic><topic>Life Sciences</topic><topic>Lung disease</topic><topic>Lung Diseases - epidemiology</topic><topic>Lupus Erythematosus, Systemic - epidemiology</topic><topic>Male</topic><topic>Mass Screening - methods</topic><topic>Middle Aged</topic><topic>Multimorbidity</topic><topic>Polymyositis</topic><topic>Psoriatic arthritis</topic><topic>Rheumatic Diseases - epidemiology</topic><topic>Rheumatoid arthritis</topic><topic>Rhumatology and musculoskeletal system</topic><topic>Risk Assessment</topic><topic>Risk Factors</topic><topic>Santé publique et épidémiologie</topic><topic>Screening</topic><topic>Spondylarthritis - epidemiology</topic><topic>Spondyloarthritis</topic><topic>Vaccination</topic><topic>Vasculitis - epidemiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Daïen, Claire I.</creatorcontrib><creatorcontrib>Tubery, Amandine</creatorcontrib><creatorcontrib>Beurai-Weber, Mégane</creatorcontrib><creatorcontrib>du Cailar, Guilhem</creatorcontrib><creatorcontrib>Picot, Marie-Christine</creatorcontrib><creatorcontrib>Jaussent, Audrey</creatorcontrib><creatorcontrib>Roubille, François</creatorcontrib><creatorcontrib>Cohen, Jean-David</creatorcontrib><creatorcontrib>Morel, Jacques</creatorcontrib><creatorcontrib>Bousquet, Jean</creatorcontrib><creatorcontrib>Fesler, Pierre</creatorcontrib><creatorcontrib>Combe, Bernard</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Hyper Article en Ligne (HAL)</collection><collection>Hyper Article en Ligne (HAL) (Open Access)</collection><jtitle>Joint, bone, spine : revue du rhumatisme</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Daïen, Claire I.</au><au>Tubery, Amandine</au><au>Beurai-Weber, Mégane</au><au>du Cailar, Guilhem</au><au>Picot, Marie-Christine</au><au>Jaussent, Audrey</au><au>Roubille, François</au><au>Cohen, Jean-David</au><au>Morel, Jacques</au><au>Bousquet, Jean</au><au>Fesler, Pierre</au><au>Combe, Bernard</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Relevance and feasibility of a systematic screening of multimorbidities in patients with chronic inflammatory rheumatic diseases</atitle><jtitle>Joint, bone, spine : revue du rhumatisme</jtitle><addtitle>Joint Bone Spine</addtitle><date>2019-01-01</date><risdate>2019</risdate><volume>86</volume><issue>1</issue><spage>49</spage><epage>54</epage><pages>49-54</pages><issn>1297-319X</issn><eissn>1778-7254</eissn><abstract>•Systematic screening of multimorbidities is efficient.•Systematic screening of multimorbidities is feasible in one-day clinic.•Screening for lung diseases should be added to this systematic screening.
EULAR recently proposed to screen multimorbidities in chronic inflammatory rheumatic diseases. The aims of the study were to define the most common multimorbidities in chronic inflammatory rheumatic diseases, compare the screening approach performed in the clinic with the recent EULAR recommendations, validate the points to consider for the systematic standardized multimorbidity screening proposed by EULAR and assess feasibility of such a screening in a daily clinic.
Data were collected prospectively during a 1-day multimorbidity clinic. Diabetes, hypertension, CVD damage, chronic respiratory diseases, osteoporosis and preventive measures were assessed. The comparison with EULAR points to consider was performed retrospectively.
We included 200 consecutive patients (157 with rheumatoid arthritis, 37 spondyloarthritis, and 6 connective tissue diseases or vasculitis). The most common multimorbidities already diagnosed in our patients were hypertension (26%) and diabetes (7.5%). Screening showed that 61.5% (CI95%: 54.6%-67.9%) patients presented at least one undiagnosed or uncontrolled diseases: diabetes (6%), hypertension (20.6%), dyslipidemia (16.1%) valvulopathies (16.8%), peripheral artery disease (4.5%); carotid stenosis (6.5%) and aortic aneurysm (5.5%). Overall, 39.9% patients had incomplete cancer screening and 52.8% incomplete vaccine schedule. Undiagnosed pulmonary obstruction and risk of sleep apnea were suspected in 15.5% and 40.1% patients, respectively.
This study underlines the relevance of a systematic screening of multimorbidities in chronic inflammatory rheumatic diseases and its feasibility in a 1-day clinic. Spirometry and sleep apnea screening should be added to EULAR points to consider. The long-term impact of such screening needs to be evaluated.</abstract><cop>France</cop><pub>Elsevier Masson SAS</pub><pmid>29654949</pmid><doi>10.1016/j.jbspin.2018.03.016</doi><tpages>6</tpages><orcidid>https://orcid.org/0000-0002-4061-4766</orcidid><orcidid>https://orcid.org/0000-0003-4204-7299</orcidid><orcidid>https://orcid.org/0000-0001-7545-6385</orcidid><orcidid>https://orcid.org/0000-0003-4002-1861</orcidid><orcidid>https://orcid.org/0000-0002-5288-9687</orcidid><orcidid>https://orcid.org/0000-0003-0636-9653</orcidid><orcidid>https://orcid.org/0000-0002-7831-6545</orcidid><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1297-319X |
| ispartof | Joint, bone, spine : revue du rhumatisme, 2019-01, Vol.86 (1), p.49-54 |
| issn | 1297-319X 1778-7254 |
| language | eng |
| recordid | cdi_hal_primary_oai_HAL_hal_01790556v2 |
| source | MEDLINE; ScienceDirect Journals (5 years ago - present) |
| subjects | Aged Arthritis, Rheumatoid - epidemiology Cardiovascular disease risk Chronic Disease - epidemiology Connective Tissue Diseases - epidemiology EULAR point to consider Feasibility Studies Female Human health and pathology Humans Life Sciences Lung disease Lung Diseases - epidemiology Lupus Erythematosus, Systemic - epidemiology Male Mass Screening - methods Middle Aged Multimorbidity Polymyositis Psoriatic arthritis Rheumatic Diseases - epidemiology Rheumatoid arthritis Rhumatology and musculoskeletal system Risk Assessment Risk Factors Santé publique et épidémiologie Screening Spondylarthritis - epidemiology Spondyloarthritis Vaccination Vasculitis - epidemiology |
| title | Relevance and feasibility of a systematic screening of multimorbidities in patients with chronic inflammatory rheumatic diseases |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-12T14%3A08%3A56IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_hal_p&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Relevance%20and%20feasibility%20of%20a%20systematic%20screening%20of%20multimorbidities%20in%20patients%20with%20chronic%20inflammatory%20rheumatic%20diseases&rft.jtitle=Joint,%20bone,%20spine%20:%20revue%20du%20rhumatisme&rft.au=Da%C3%AFen,%20Claire%20I.&rft.date=2019-01-01&rft.volume=86&rft.issue=1&rft.spage=49&rft.epage=54&rft.pages=49-54&rft.issn=1297-319X&rft.eissn=1778-7254&rft_id=info:doi/10.1016/j.jbspin.2018.03.016&rft_dat=%3Cproquest_hal_p%3E2025318810%3C/proquest_hal_p%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2025318810&rft_id=info:pmid/29654949&rft_els_id=S1297319X18300599&rfr_iscdi=true |